Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -4,398,453 (Position Closed) | Filing History |
| 2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Citadel Advisors LLC | 5,406,089 7.600% | 1,819,325 (+50.72%) | Filing History |
| 2024-02-14 4:13 pm Purchase | 2024-02-05 | 13G | Aclaris Therapeutics, Inc. ACRS | Integrated Core Strategies (Asia) Pte. Ltd. | 3,769,926 5.300% | 290,565 (+8.35%) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | TANG CAPITAL PARTNERS LP | 1,753,335 2.500% | -2,584,820 (-59.58%) | Filing History |
| 2024-02-14 2:06 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Rock Springs Capital Management LP | 2,998,495 4.230% | -962,754 (-24.30%) | Filing History |
| 2024-02-14 10:30 am Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -3,360,941 (Position Closed) | Filing History |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | Aclaris Therapeutics, Inc. ACRS | The Vanguard Group | 4,721,887 6.670% | 4,721,887 (New Position) | Filing History |
| 2024-02-13 2:24 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Foresite Capital Fund IV, L.P. | 0 0.000% | -4,066,277 (Position Closed) | Filing History |
| 2024-02-08 11:14 am Purchase | 2024-02-07 | 13G | Aclaris Therapeutics, Inc. ACRS | BML Investment Partners, L.P. | 9,395,934 13.300% | 4,895,934 (+108.80%) | Filing History |
| 2024-02-01 4:15 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Integrated Core Strategies (Asia) Pte. Ltd. | 3,479,361 4.900% | -108,753 (-3.03%) | Filing History |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | BlackRock Inc. BLK | 5,905,872 8.300% | 818,437 (+16.09%) | Filing History |
| 2024-01-16 5:24 pm Purchase | 2024-01-11 | 13G | Aclaris Therapeutics, Inc. ACRS | BML Investment Partners, L.P. | 4,500,000 6.400% | 4,500,000 (New Position) | Filing History |
| 2023-12-11 4:25 pm Purchase | 2023-12-07 | 13G | Aclaris Therapeutics, Inc. ACRS | Integrated Core Strategies (Asia) Pte. Ltd. | 3,588,114 5.100% | 3,588,114 (New Position) | Filing History |
| 2023-12-11 09:36 am Sale | 2023-11-30 | 13G | Aclaris Therapeutics, Inc. ACRS | WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% | -7,372,601 (Position Closed) | Filing History |
| 2023-11-24 1:49 pm Purchase | 2023-11-14 | 13G | Aclaris Therapeutics, Inc. ACRS | TANG CAPITAL PARTNERS LP | 4,338,155 6.100% | 4,338,155 (New Position) | Filing History |
| 2023-09-05 4:14 pm Purchase | 2023-08-25 | 13G | Aclaris Therapeutics, Inc. ACRS | Citadel Advisors LLC | 3,586,764 5.100% | 3,586,764 (New Position) | Filing History |
| 2023-04-10 09:06 am Purchase | 2023-03-31 | 13G | Aclaris Therapeutics, Inc. ACRS | WELLINGTON MANAGEMENT GROUP LLP | 7,372,601 11.050% | 1,888,588 (+34.44%) | Filing History |
| 2023-03-16 4:48 pm Purchase | 2023-03-06 | 13G | Aclaris Therapeutics, Inc. ACRS | BIOTECHNOLOGY VALUE FUND L P | 3,360,941 5.000% | 84,398 (+2.58%) | Filing History |
| 2023-02-14 2:49 pm Purchase | 2022-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Rock Springs Capital Management LP | 3,961,249 5.940% | 99,902 (+2.59%) | Filing History |
| 2023-02-14 11:40 am Sale | 2022-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | BIOTECHNOLOGY VALUE FUND L P | 3,276,543 4.900% | -591,500 (-15.29%) | Filing History |